MyAverix Finance
US · Healthcare
Apimeds Pharmaceuticals US, Inc. (APUS)
Drug Manufacturers - Specialty & Generic
Apimeds Pharmaceuticals US, Inc. (APUS) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for APUS
Apimeds Pharmaceuticals US, Inc. (APUS) — FAQ
What is APUS's P/E ratio?
The price-to-earnings (P/E) ratio for Apimeds Pharmaceuticals US, Inc. (APUS) is 18.00 (data as of 2026-03-23).
Does Apimeds Pharmaceuticals US, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Apimeds Pharmaceuticals US, Inc. (APUS). Check the MyAverix Finance app for the latest dividend data.
What sector is Apimeds Pharmaceuticals US, Inc. in?
Apimeds Pharmaceuticals US, Inc. (APUS) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is APUS listed on?
APUS is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.